Atlas Trials

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer

Clinical trial NCT04113863 · TERMINATED

Trial details

NCT number
NCT04113863
Sponsor
Mario Negri Institute for Pharmacological Research
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasm Female
Start date
2019-06-18
Primary completion
2025-01-30
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.